vTv Therapeutics (VTVT) Receivables - Net (2017 - 2024)
vTv Therapeutics' Receivables - Net history spans 10 years, with the latest figure at $62000.0 for Q4 2024.
- For Q4 2024, Receivables - Net fell 39.22% year-over-year to $62000.0; the TTM value through Dec 2024 reached $62000.0, down 39.22%, while the annual FY2024 figure was $62000.0, 39.22% down from the prior year.
- Receivables - Net for Q4 2024 was $62000.0 at vTv Therapeutics, down from $242000.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $981000.0 in Q1 2024 and bottomed at $2000.0 in Q1 2021.
- The 5-year median for Receivables - Net is $77000.0 (2022), against an average of $214733.3.
- The largest annual shift saw Receivables - Net soared 6528.57% in 2021 before it tumbled 93.86% in 2022.
- A 5-year view of Receivables - Net shows it stood at $158000.0 in 2020, then crashed by 63.92% to $57000.0 in 2021, then soared by 203.51% to $173000.0 in 2022, then plummeted by 41.04% to $102000.0 in 2023, then crashed by 39.22% to $62000.0 in 2024.
- Per Business Quant, the three most recent readings for VTVT's Receivables - Net are $62000.0 (Q4 2024), $242000.0 (Q3 2024), and $306000.0 (Q2 2024).